BCLI - Brainstorm Cell Therapeutics Inc logo

Brainstorm Cell Therapeutics Inc

BCLI

Brainstorm Cell Therapeutics develops autologous cellular therapies for neurodegenerative diseases. Its NurOwn platform leverages bone marrow-derived stem cells to treat conditions like amyotrophic lateral sclerosis and multiple sclerosis.

βš•οΈ Healthcare NASDAQ Listed 2003 $ USD
$1,000 invested 20 years ago β†’$12today

Score Overview

1 Year
Score
Net Growth-188.68%
Net TrendShrank
Net Income Consistencyβ€”
Rev Growth-17.20%
Rev TrendShrank
Revenue Consistencyβ€”
5 Years
Scoreβ€”
Net Growth67.60%
Net Trend80%
Net Income Consistencyβ€”
Rev Growthβ€”
Rev Trend20%
Revenue Consistencyβ€”
10 Years
Scoreβ€”
Net Growth-21.43%
Net Trend60%
Net Income Consistency
Rev Growthβ€”
Rev Trend20%
Revenue Consistency
20 Years
Scoreβ€”
Net Growth-210.76%
Net Trend50%
Net Income Consistency
Rev Growthβ€”
Rev Trend14%
Revenue Consistency
All Time
Scoreβ€”
Net Growth-138x
Net Trend50%
Net Income Consistency
Rev Growthβ€”
Rev Trend14%
Revenue Consistency

Explore the 2021 public Archive ranking β†’

Where Brainstorm Cell Therapeutics Inc has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by Net Income Growth.

Has not reached the top 50 on Net Income Growth in any year we have ranked.

  • BCLI

2014: 99.4% Β· 2021: 95.9% Β· free through 2021 Β· longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-13
$ 0.77β€”
1 Year2025-10-13
$ 0.6617.17%
5 Years2021-10-13
$ 47.25-98.36%
10 Years2016-10-13
$ 34.95-97.79%
20 Years2006-10-13
$ 65.25-98.81%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
2025$ 703K-$ 10M$ 29K
2024$ 849K$ 11M$ 187K
2023$ 0.00-$ 17M$ 1M
2022$ 0.00-$ 23M$ 2M
2021$ 0.00-$ 24M$ 22M
2020$ 0.00-$ 31M$ 41M
2019-$ 366K-$ 23M$ 569K
2018$ 0.00-$ 13M$ 7M
2017$ 0.00-$ 4M$ 7M
2016$ 0.00-$ 4M$ 9M
2015$ 0.00-$ 8M$ 15M
2014$ 0.00-$ 9M$ 8M
2013$ 0.00-$ 4M$ 3M
2012$ 0.00-$ 3M$ 4M
2011$ 0.00-$ 3M$ 1M
2010-$ 2M$ 93K
2009-$ 1M$ 1K
2008-$ 3M$ 2K
2007-$ 6M$ 86K
2006-$ 3M$ 60K
2005-$ 3M$ 290.22K
2004-$ 18M$ 526.52K
IPO2003-$ 73.3K$ 4.6K
BCLI - Brainstorm Cell Therapeutics Inc logo

Brainstorm Cell Therapeutics Inc fundamental performance

Across Brainstorm Cell Therapeutics Inc's full reported history, from 2003 to 2025, net income went from -$ 73.3K to -$ 10M. Revenue increased in 14% of the years measured; net income in 50%.

Membership

Continue BCLI’s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,125 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year Β· Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies